THERE’S NO ‘AVERAGE’ CANCER PATIENT
JUNE 20, 2011 What the late Stephen Jay Gould could teach the FDA. By GREGORY CONKO On June 28, the Food and Drug Administration (FDA) will hold a hearing to decide the fate of Avastin, a drug taken by thousands of women fighting late-stage breast cancer. Many of these women have pleaded for continued access […]
THERE’S NO ‘AVERAGE’ CANCER PATIENT Read More »